Factor XI deficiency

Seminars in Thrombosis and Hemostasis

Volumn 35, Issue 4, 2009, Pages 416-425

  Duga, Stefano ^a   Salomon, Ophira ^b,c  

^a UNIVERSITY OF MILAN   (Italy)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Bleeding; CRM+; Factor XI; Founder effect; Inhibitors; Treatment

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 11; FRESH FROZEN PLASMA; RECOMBINANT ACTIVATED FACTOR 7; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT PROTEIN; RHESUS D ANTIBODY; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

BLOOD CLOTTING FACTOR 11 DEFICIENCY; CLINICAL FEATURE; DISEASE ASSOCIATION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HEMOPHILIA; HUMAN; JEW; LABORATORY TEST; LOW DRUG DOSE; LUNG EMBOLISM; MENORRHAGIA; MYCOSIS; NONHUMAN; NULL ALLELE; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; VENOUS THROMBOEMBOLISM;

ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION FACTOR INHIBITORS; FACTOR XI; FACTOR XI DEFICIENCY; FACTOR XIA; FEMALE; FOUNDER EFFECT; GENOTYPE; HEMORRHAGE; HUMANS; INFANT, NEWBORN; JEWS; MALE; MENORRHAGIA; MUTATION; PHENOTYPE; POSTPARTUM HEMORRHAGE; PREGNANCY; PRENATAL DIAGNOSIS; PREOPERATIVE CARE; THROMBOSIS;

EID: 67749102041     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0029-1225764     Document Type: Review

References (87)

1. Seligsohn U. Factor XI in haemostasis and thrombosis: past, present and future. Thromb Haemost 2007;98:84-89 (Pubitemid 47074182)
2. Rosenthal RL, Dreskin OH, Rosenthal N. New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc Soc Exp Biol Med 1953;82: 171-174
3. Kravtsov DV, Wu W, Meijers JC, et al. Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. Blood 2004;104:128-134 (Pubitemid 38879848)
4. Kravtsov DV, Monahan PE, Gailani D. A classification system for cross-reactive material-negative factor XI deficiency. Blood 2005;105:4671-4673 (Pubitemid 40807287)
5. Peyvandi F, Lak M, Mannucci PM. Factor XI deficiency in Iranians: its clinical manifestations in comparison with those of classic hemophilia. Haematologica 2002;87:512-514 (Pubitemid 34533277)
6. Shpilberg O, Peretz H, Zivelin A, et al. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood 1995;85:429-432
7. Mitchell M, Mountford R, Butler R, et al. Spectrum of factor XI (F11) mutations in the UK population-116 index cases and 140 mutations. Hum Mutat 2006;27:829
8. Zadra G, Asselta R, Tenchini ML, et al. Simultaneous genotyping of coagulation factor XI type II and type III mutations by multiplex real-time polymerase chain reaction to determine their prevalence in healthy and factor XI-deficient Italians. Haematologica 2008;93:715-721 (Pubitemid 351669311)
9. Salomon O, Steinberg DM, Seligshon U. Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy. Haemophilia 2006;12:490-493 (Pubitemid 44227591)
10. Bouma BN, Meijers JC. Role of blood coagulation factor XI in downregulation of fibrinolysis. Curr Opin Hematol 2000; 7:266-272 (Pubitemid 30637664)
11. Kadir RA, Economides DL, Sabin CA, Owens D, Lee A. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998;351:485-489 (Pubitemid 28070095)
12. Salomon O, Zivelin A, Livnat T, et al. Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency. Blood 2003;101:4783-4788 (Pubitemid 36857735)
13. Zucker M, Zivelin A, Teitel J, Seligsohn U. Induction of an inhibitor antibody to factor XI in a patient with severe inherited factor XI deficiency by Rh immune globulin. Blood 2008;111:1306-1308 (Pubitemid 351213416)
14. Quélin F, Trossaërt M, Sigaud M, Mazancourt PD, Fressinaud E. Molecular basis of severe factor XI deficiency in seven families from the west of France. Seven novel mutations, including an ancient Q88X mutation. J Thromb Haemost 2004;2:71-76 (Pubitemid 40185622)
15. Vercellotti GM, Mosher DF. Acquired factor XI deficiency in systemic lupus erythematosus. Thromb Haemost 1982;48: 250-252 (Pubitemid 13209585)
16. Bortoli R, Monticielo OA, Chakar RM, et al. Acquired factor XI inhibitor in systemic lupus erythematosus: case report and literature review. Semin Arthritis Rheum 2009 (Epub ahead of print)
17. Goodrick MJ, Prentice AG, Copplestone JA, Pamphilon DH, Boon RJ. Acquired factor XI inhibitor in chronic lymphocytic leukaemia. J Clin Pathol 1992;45:352-353
18. Billon S, Le Niger C, Escoffre-Barbe M, Vicariot M, Abgrall JF. The use of recombinant factor VIIa (NovoSeven) in a patient with a factor XI deficiency and a circulating anticoagulant. Blood Coagul Fibrinolysis 2001;12:551-553 (Pubitemid 33022519)
19. Delios G, Pollio B, Tucciarone M, et al. Successful use of recombinant factor VIIa in a patient with paraneoplastic factor XI inhibitor. Haemophilia 2008;14:160-162
20. Kyriakou DS, Alexandrakis MG, Passam FH, et al. Acquired inhibitors to coagulation factors in patients with gastrointestinal diseases. Eur J Gastroenterol Hepatol 2002;14: 1383-1387
21. Salomon O, Steinberg DM, Tamarin I, Zivelin A, Seligsohn U. Plasma replacement therapy during labor is not mandatory for women with severe factor XI deficiency. Blood Coagul Fibrinolysis 2005;16:37-41
22. Myers B, Pavord S, Kean L, Hill M, Dolan G. Pregnancy outcome in factor XI deficiency: incidence of miscarriage, antenatal and postnatal haemorrhage in 33 women with factor XI deficiency. BJOG 2007;114:643-646 (Pubitemid 46587966)
23. Tarantino MD, Gupta SL, Brusky RM. The incidence and outcome of intracranial haemorrhage in newborns with haemophilia: analysis of the Nationwide Inpatient Sample database. Haemophilia 2007;13:380-382
24. Peretz H, Mulai A, Usher S, et al. The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin. Blood 1997;90: 2654-2659 (Pubitemid 27413475)
25. Zivelin A, Bauduer F, Ducout L, et al. Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood 2002;99: 2448-2454 (Pubitemid 34525431)
26. Bolton-Maggs PH, Peretz H, Butler R, et al. A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency. J Thromb Haemost 2004;2:918-924 (Pubitemid 40185739)
27. Bolton-Maggs PHB, Young Wan-Yin B, McCraw AH, Slack J, Kernoff PB. Inheritance and bleeding in factor XI deficiency. Br J Haematol 1988;69:521-528
28. Salomon O, Steinberg DM, Koren-Morag N, Tanne D, Seligsohn U. Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood 2008;111: 4113-4117
29. Umeda T, Hiramaru M, Nishino T, Onchi K, Matsuda T. A case of congenital factor XI (plasma thromboplastin antecedent) deficiency with large organized thrombus in the vena cava inferior. Nippon Ketsueki Gakkai Zasshi 1968;31:325-333
30. Brodsky JB, Burgess GE III. Pulmonary embolism with factor XI deficiency. JAMA 1975;234:1156-1157
31. Evans G, Pasi KJ, Mehta A, Lee CA, Perry DJ. Recurrent venous thromboembolic disease and factor XI concentrate in a patient with severe factor XI deficiency, chronic myelomonocytic leukaemia, factor V Leiden and heterozygous plasminogen deficiency. Blood Coagul Fibrinolysis 1997;8:437-440 (Pubitemid 27475690)
32. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000;342:696-701 (Pubitemid 30131422)
33. Loeser WD, Dickstein ES. Factor XI deficiency in a geriatric population. Ohio Med 1988;84:416-417
34. Tucker EI, Gailani D, Hurst S, Cheng Q, Hanson SR, Gruber A. Survival advantage of coagulation factor XI-deficient mice during peritoneal sepsis. J Infect Dis 2008; 198:271-274 (Pubitemid 352019293)
35. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004;104:1243-1252
36. Zadra G, Asselta R, Malcovati M, et al. Molecular genetic analysis of severe coagulation factor XI deficiency in six Italian patients. Haematologica 2004;89:1332-1340 (Pubitemid 39540570)
37. Tarumi T, Kravtsov DV, Zhao M, Williams SM, Gailani D. Cloning and characterization of the human factor XI gene promoter: transcription factor hepatocyte nuclear factor 4alpha (HNF-4alpha ) is required for hepatocyte-specific expression of factor XI. J Biol Chem 2002;277:18510-18516 (Pubitemid 34952400)
38. Hsu TC, Shore SK, Seshsmma T, Bagasra O, Walsh PN. Molecular cloning of platelet factor XI, an alternative splicing product of the plasma factor XI gene. J Biol Chem 1998; 273:13787-13793 (Pubitemid 28268428)
39. Lipscomb MS, Walsh PN. Human platelets and factor XI. Localization in platelet membranes of factor XI-like activity and its functional distinction from plasma factor XI. J Clin Invest 1979;63:1006-1014
40. Tuszynski GP, Bevacqua SJ, Schmaier AH, Colman RW, Walsh PN. Factor XI antigen and activity in human platelets. Blood 1982;59:1148-1156 (Pubitemid 12074840)
41. Walsh PN. Roles of platelets and factor XI in the initiation of blood coagulation by thrombin. Thromb Haemost 2001;86: 75-82 (Pubitemid 32663939)
42. Podmore A, Smith M, Savidge G, Alhaq A. Real-time quantitative PCR analysis of factor XI mRNA variants in human platelets. J Thromb Haemost 2004;2:1713-1719 (Pubitemid 40192710)
43. Soldà G, Asselta R, Ghiotto R, Tenchini ML, Castaman G, Duga S. A type II mutation (Glu117stop), induction of allele-specific mRNA degradation and factor XI deficiency. Haematologica 2005;90:1716-1718 (Pubitemid 41815007)
44. Guella I, Asselta R, Rimoldi V, Tenchini ML, Duga S. Characterization of the F11 alternative splicing pattern: identification of a novel coagulation FXI isoform. J Thromb Haemost 2007;5(Suppl 2):PW003
45. Lejeune F, Maquat LE. Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells. Curr Opin Cell Biol 2005;17:309-315 (Pubitemid 40719922)
46. Thompson RE, Mandle RJr, Kaplan AP. Association of factor XI and high molecular weight kininogen in human plasma. J Clin Invest 1977;60:1376-1380 (Pubitemid 8238653)
47. Fujikawa K, Chung DW, Hendrickson LE, Davie EW. Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein. Biochemistry 1986; 25:2417-2424
48. McMullen BA, Fujikawa K, Davie EW. Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains. Biochemistry 1991;30:2056-2060
49. Papagrigoriou E, McEwan PA, Walsh PN, Emsley J. Crystal structure of the factor XI zymogen reveals a pathway for transactivation. Nat Struct Mol Biol 2006;13:557-558 (Pubitemid 43848912)
50. Sinha D, Marcinkiewicz M, Gailani D, Walsh PN. Molecular cloning and biochemical characterization of rabbit factor XI. Biochem J 2002;367(Pt 1):49-56 (Pubitemid 35176890)
51. Wu W, Sinha D, Shikov S, et al. Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa. J Biol Chem 2008; 283:18655-18664
52. Gailani D, Broze GJ Jr. Factor XI activation in a revised model of blood coagulation. Science 1991;253:909-912 (Pubitemid 21917236)
53. Di Scipio RG, Kurachi K, Davie EW. Activation of human factor IX (Christmas factor). J Clin Invest 1978;61:1528-1538
54. von dem Borne PAK, Meijers JCM, Bouma BN. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 1995;86:3035-3042
55. Walsh PN. Retraction of: " Baglia FA, Walsh PN. Biochemistry. 1998 Feb 24;37(8):2271-81. Biochemistry 2007;46:12886-12887
56. Pedicord DL, Seiffert D, Blat Y. Feedback activation of factor XI by thrombin does not occur in plasma. Proc Natl Acad Sci U S A 2007;104:12855-12860 (Pubitemid 47255244)
57. Gailani D, Lasky NM, Broze GJ Jr. A murine model of factor XI deficiency. Blood Coagul Fibrinolysis 1997;8:134-144
58. Renné T, Pozgajová M, Grüner S, et al. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 2005;202:271-281 (Pubitemid 41043823)
59. Kannemeier C, Shibamiya A, Nakazawa F, et al. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A 2007;104:6388-6393 (Pubitemid 47186104)
60. Smith SA, Mutch NJ, Baskar D, Rohloff P, Docampo R, Morrissey JH. Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci U S A 2006;103:903-908 (Pubitemid 43212194)
61. Saunders RE, O'Connell NM, Lee CA, Perry DJ, Perkins SJ. Factor XI deficiency database: an interactive web database of mutations, phenotypes, and structural analysis tools. Hum Mutat 2005;26:192-198
62. Dossenbach-Glaninger A, Hopmeier P. Coagulation factor XI: a database of mutations and polymorphisms associated with factor XI deficiency. Blood Coagul Fibrinolysis 2005; 16:231-238 (Pubitemid 40705043)
63. Martincic D, Zimmerman SA, Ware RE, Sun MF, Whitlock JA, Gailani D. Identification of mutations and polymorphisms in the factor XI genes of an African American family by dideoxyfingerprinting. Blood 1998;92:3309-3317 (Pubitemid 28492339)
64. Zivelin A, Ogawa T, Bulvik S, et al. Severe factor XI deficiency caused by a Gly555 to Glu mutation (factor XI-Glu555): a cross-reactive material positive variant defective in factor IX activation. J Thromb Haemost 2004;2:1782-1789 (Pubitemid 40192720)
65. Germanos-Haddad M, de Moerloose P, Boehlen F, Peyvandi F, Neerman-Arbez M. Homozygosity for a Thr575Met missense mutation in the catalytic domain associated with factor XI deficiency. Haematologica 2005;90:418-419 (Pubitemid 40389001)
66. Sun MF, Ho D, Martincic D, Ware RE, Walsh PN, Gailani D. Defective binding of factor XI-N248 to activated human platelets. Blood 2007;110:4164
67. Gailani D, Schmidt A, Sun MF, Bolton-Maggs PH, Bajaj SP. A cross-reactive material positive variant of coagulation factor XI (FXIP520L) with a catalytic defect. J Thromb Haemost 2007;5:781-787 (Pubitemid 46563578)
68. Bozzao C, Rimoldi V, Asselta R, et al. A novel factor XI missense mutation (Val371Ile) in the activation loop is responsible for a case of mild type II factor XI deficiency. FEBS J 2007;274:6128-6138 (Pubitemid 350135334)
69. Mitchell M, Dai L, Savidge G, Alhaq A. An Alu-mediated 31.5-kb deletion as the cause of factor XI deficiency in 2 unrelated patients. Blood 2004;104:2394-2396 (Pubitemid 39331838)
70. Zucker M, Zivelin A, Landau M, et al. Characterization of seven novel mutations causing factor XI deficiency. Haematologica 2007;92:1375-1380 (Pubitemid 350144155)
71. Asakai R, Chung DW, Ratnoff OD, Davie EW. Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations. Proc Natl Acad Sci U S A 1989;86:7667-7671
72. Peretz H, Zivelin A, Usher S, Seligsohn U. A 14-bp deletion (codon 554 del AAGgtaacagagtg) at exon 14/intron N junction of the coagulation factor XI gene disrupts splicing and causes severe factor XI deficiency. Hum Mutat 1996; 8:77-78 (Pubitemid 26238974)
73. Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991; 325:153-158
74. Meijers JC, Davie EW, Chung DW. Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency. Blood 1992;79:1435-1440
75. Gailani D, Zivelin A, Sinha D, Walsh PN. Do platelets synthesize factor XI? J Thromb Haemost 2004;2:1709-1712
76. Guella I, Soldà G, Spena S, et al. Molecular characterization of two novel mutations causing factor XI deficiency: a splicing defect and a missense mutation responsible for a CRM+ defect. Thromb Haemost 2008;99:523-530 (Pubitemid 351549288)
77. Imanaka Y, Lal K, Nishimura T, Bolton-Maggs PH, Tuddenham EG, McVey JH. Identification of two novel mutations in non-Jewish factor XI deficiency. Br J Haematol 1995;90:916-920
78. Mitchell M, Harrington P, Cutler J, Rangarajan S, Savidge G, Alhaq A. Eighteen unrelated patients with factor XI deficiency, four novel mutations and a 100% detection rate by denaturing high-performance liquid chromatography. Br J Haematol 2003;121:500-502 (Pubitemid 36628345)
79. Gomez K, Bolton-Maggs P. Factor XI deficiency. Haemophilia 2008;14:1183-1189
80. Mannucci PM, Bauer KA, Santagostino E, et al. Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patients. Blood 1994; 15:1314-1319 (Pubitemid 24245901)
81. Salomon O, Zivelin A, Livnat T, Seligsohn U. Inhibitors to factor XI in patients with severe factor XI deficiency. Semin Hematol 2006;43(1, Suppl 1):S10-S12 (Pubitemid 43150492)
82. O'Connell NM, Riddell AF, Pascoe G, Perry DJ, Lee CA. Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency. Haemophilia 2008;14:775-781 (Pubitemid 352016034)
83. Schulman S, Nemeth G. An illustrative case and a review on the dosing of recombinant factor VIIa in congenital factor XI deficiency. Haemophilia 2006;12:223-227
84. Cid AR, Lorenzo JI, Haya S, Montoro JM, Casaña P, Aznar JA. A comparison of FVII:C and FVIIa assays for the monitoring of recombinant factor VIIa treatment. Haemophilia 2001;7:39-41 (Pubitemid 32162196)
85. Livnat T, Zivelin A, Martinowitz U, Salomon O, Seligsohn U. Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI. J Thromb Haemost 2006;4:192-200
86. Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med 2007;356:2301-2311
87. Franchini M, de Gironcoli M, Lippi G, Manzato F, Aprili G, Gandini G. Prophylactic use of desmopressin in surgery of six patients with symptomatic heterozygous factor XI deficiency. Haematologica 2000;85:106-107 (Pubitemid 30096905)